CIK: 0001773195 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $358,275 (91.6% shares, 8.4% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 250,000 | $89,295 | 24.9% | — | — | Put | 78462F103 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 326,668 | $17,839 | 5.0% | $63.72 | -6.2% | COM | G31249108 |
| — | CHINOOK THERAPEUTICS INC | 813,998 | $16,003 | 4.5% | $16.39 | — | COM | 16961L106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 190,000 | $12,939 | 3.6% | $68.10 | — | COM | 37890U108 |
| IWM | ISHARES TR | 70,000 | $11,544 | 3.2% | — | — | Put | 464287655 |
| SNY | SANOFI | 300,000 | $11,406 | 3.2% | $38.02 | — | SPONSORED ADR | 80105N105 |
| — | TRAVERE THERAPEUTICS INC | 11,000,000 | $11,131 | 3.1% | $0.98 | — | NOTE 2.500% 9/1 | 761299AB2 |
| ASND | ASCENDIS PHARMA A/S | 100,000 | $10,326 | 2.9% | $116.37 | — | SPONSORED ADR | 04351P101 |
| SNY | SANOFI | 250,000 | $9,505 | 2.7% | $38.02 | — | Put | 80105N105 |
| KURA | KURA ONCOLOGY INC | 675,753 | $9,231 | 2.6% | $23.45 | -34.2% | COM | 50127T109 |
| LNTH | LANTHEUS HLDGS INC | 130,000 | $9,143 | 2.6% | $42.08 | +80.0% | COM | 516544103 |
| — | INARI MED INC | 120,000 | $8,717 | 2.4% | $91.64 | — | COM | 45332Y109 |
| — | NANOSTRING TECHNOLOGIES INC | 10,000,000 | $8,544 | 2.4% | $1.02 | — | NOTE 2.625% 3/0 | 63009RAD1 |
| AZN | ASTRAZENECA PLC | 150,000 | $8,226 | 2.3% | $61.36 | — | SPONSORED ADR | 046353108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 100,000 | $6,499 | 1.8% | $80.21 | -13.4% | COM | 558868105 |
| VTYX | VENTYX BIOSCIENCES INC | 170,000 | $5,935 | 1.7% | $22.14 | 0.0% | COM | 92332V107 |
| — | POINT BIOPHARMA GLOBAL INC | 746,576 | $5,771 | 1.6% | $7.70 | — | COM | 730541109 |
| AZN | ASTRAZENECA PLC | 100,000 | $5,484 | 1.5% | $61.36 | — | Put | 046353108 |
| — | BELLUS HEALTH INC NEW | 473,597 | $5,001 | 1.4% | $5.18 | — | COM NEW | 07987C204 |
| — | SPRINGWORKS THERAPEUTICS INC | 175,000 | $4,993 | 1.4% | $28.53 | — | COM | 85205L107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 75,000 | $4,874 | 1.4% | $80.21 | -13.4% | Put | 558868105 |
| PEN | PENUMBRA INC | 25,000 | $4,740 | 1.3% | — | — | Call | 70975L107 |
| — | CYMABAY THERAPEUTICS INC | 1,290,511 | $4,517 | 1.3% | $3.32 | — | COM | 23257D103 |
| — | BRIDGEBIO PHARMA INC | 7,500,000 | $4,491 | 1.3% | $0.74 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| — | BRIDGEBIO PHARMA INC | 10,000,000 | $4,437 | 1.2% | $0.47 | — | NOTE 2.250% 2/0 | 10806XAD4 |
| RCKT | ROCKET PHARMACEUTICALS INC | 267,794 | $4,274 | 1.2% | $25.12 | -37.9% | COM | 77313F106 |
| — | MORPHIC HLDG INC | 146,491 | $4,146 | 1.2% | $50.29 | — | COM | 61775R105 |
| ACLX | ARCELLX INC | 210,138 | $3,944 | 1.1% | $16.91 | +13.1% | COMMON STOCK | 03940C100 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 170,000 | $3,682 | 1.0% | $39.22 | -30.3% | COM | 98943L107 |
| — | ASTRIA THERAPEUTICS INC | 400,043 | $3,616 | 1.0% | $9.04 | — | COM | 04635X102 |
| — | VERONA PHARMA PLC | 350,000 | $3,577 | 1.0% | $10.22 | — | SPONSORED ADR | 925050106 |
| — | ARYA SCIENCES ACQUISITN CORP | 352,500 | $3,465 | 1.0% | $9.88 | — | CLASS A ORD SHS | G31658100 |
| GSK | GSK PLC | 110,000 | $3,237 | 0.9% | $29.43 | — | Put | 37733W204 |
| CYTK | CYTOKINETICS INC | 65,000 | $3,149 | 0.9% | $46.31 | +3.9% | COM NEW | 23282W605 |
| COGT | COGENT BIOSCIENCES INC | 154,087 | $2,299 | 0.6% | $8.12 | +68.7% | COM | 19240Q201 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 80,000 | $2,249 | 0.6% | $32.19 | -4.7% | COM NEW | 15117B202 |
| GSK | GSK PLC | 75,000 | $2,207 | 0.6% | $29.43 | — | SPONSORED ADR | 37733W204 |
| ACRS | ACLARIS THERAPEUTICS INC | 136,434 | $2,147 | 0.6% | $17.96 | -12.3% | COM | 00461U105 |
| LNTH | LANTHEUS HLDGS INC | 30,000 | $2,110 | 0.6% | $42.08 | +80.0% | Put | 516544103 |
| — | VINCERX PHARMA INC | 1,492,771 | $2,060 | 0.6% | $13.47 | — | COM NEW | 92731L106 |
| FXE | INVESCO CURRENCYSHARES EURO | 20,000 | $1,809 | 0.5% | — | — | Put | 46138K103 |
| — | VERONA PHARMA PLC | 165,100 | $1,687 | 0.5% | $10.22 | — | Put | 925050106 |
| GERN | GERON CORP | 650,000 | $1,521 | 0.4% | — | — | Put | 374163103 |
| — | PROMETHEUS BIOSCIENCES INC | 25,000 | $1,475 | 0.4% | $59.00 | — | COM | 74349U108 |
| GERN | GERON CORP | 626,000 | $1,465 | 0.4% | — | — | Call | 374163103 |
| — | PRECIGEN INC | 1,500,000 | $1,455 | 0.4% | $0.97 | — | NOTE 3.500% 7/0 | 46122TAA0 |
| KALV | KALVISTA PHARMACEUTICALS INC | 96,318 | $1,398 | 0.4% | $13.98 | 0.0% | COM | 483497103 |
| MIST | MILESTONE PHARMACEUTICALS IN | 137,200 | $1,261 | 0.4% | — | — | Call | 59935V107 |
| LIANY | LIANBIO | 550,000 | $1,095 | 0.3% | $3.37 | — | SPONSORED ADS | 53000N108 |
| FXB | INVESCO CURRENCYSHARES BRIT | 10,000 | $1,073 | 0.3% | — | — | Put | 46138M109 |
| CNTX | CONTEXT THERAPEUTICS INC | 883,654 | $981 | 0.3% | $2.08 | -13.3% | COM | 21077P108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 242,517 | $975 | 0.3% | $4.02 | — | SPONSORED ADS | 152309100 |
| — | ALPINE IMMUNE SCIENCES INC | 110,000 | $792 | 0.2% | $7.20 | — | COM | 02083G100 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 372,476 | $790 | 0.2% | $10.24 | -75.4% | COM | 63909J108 |
| — | VERVE THERAPEUTICS INC | 20,000 | $687 | 0.2% | — | — | Call | 92539P101 |
| VKTX | VIKING THERAPEUTICS INC | 250,000 | $680 | 0.2% | $3.28 | 0.0% | COM | 92686J106 |
| — | IVERIC BIO INC | 30,000 | $538 | 0.2% | — | — | Call | 46583P102 |
| — | IMMATICS N.V | 187,204 | $507 | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| KURA | KURA ONCOLOGY INC | 37,100 | $507 | 0.1% | $23.45 | -34.2% | Put | 50127T109 |
| — | RENOVACOR INC | 199,490 | $503 | 0.1% | $7.19 | — | COM | 75989E106 |
| TNGX | TANGO THERAPEUTICS INC | 81,982 | $297 | 0.1% | $4.27 | 0.0% | COM | 87583X109 |
| — | VICKERS VANTAGE CORP I | 100,000 | $17 | 0.0% | $0.17 | — | *W EXP 09/15/202 | G9440B115 |
| — | RENOVACOR INC | 75,000 | $6 | 0.0% | $0.80 | — | *W EXP 99/99/999 | 75989E114 |
| — | MEDICUS SCIENCES ACQUISITION | 33,333 | $3 | 0.0% | $1.02 | — | *W EXP 02/12/202 | G5960S124 |